Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
1776
DELISTED
Diebold Nixdorf Incorporated
DBD
| $5.64M | ﹤0.01% |
534,000
+36,193
| +7% | +$321K |
|
1777
AdvanSix
ASIX
$460M
| $5.64M | ﹤0.01% |
282,400
-111,400
| -28% | -$2.43M |
|
1778
Group 1 Automotive
GPI
$3.15B
| $5.63M | ﹤0.01% |
56,290
-36,810
| -40% | -$3.63M |
|
1779
Heritage Insurance Holdings
HRTG
$1.01B
| $5.61M | ﹤0.01% |
423,200
+12,200
| +3% | +$168K |
|
1780
HNI Corp
HNI
$3.53B
| $5.6M | ﹤0.01% |
149,500
+122,400
| +452% | +$4.68M |
|
|
RDUS
1781
DELISTED
Radius Recycling
RDUS
| $5.59M | ﹤0.01% |
257,892
-46,304
| -15% | -$986K |
|
|
CTG
1782
DELISTED
Computer Task Group, Inc.
CTG
| $5.59M | ﹤0.01% |
1,079,146
+65,150
| +6% | +$350K |
|
1783
Navigator Holdings
NVGS
$1.29B
| $5.57M | ﹤0.01% |
413,500
+82,200
| +25% | +$973K |
|
|
CCRD
1784
DELISTED
CoreCard
CCRD
| $5.56M | ﹤0.01% |
139,097
+20,500
| +17% | +$889K |
|
|
ELVT
1785
DELISTED
Elevate Credit, Inc.
ELVT
| $5.54M | ﹤0.01% |
1,245,616
+93,829
| +8% | +$392K |
|
1786
Badger Meter
BMI
$3.79B
| $5.53M | ﹤0.01% |
+85,100
| New | +$5.05M |
|
1787
Horace Mann Educators
HMN
$2.13B
| $5.52M | ﹤0.01% |
126,500
-79,500
| -39% | -$3.51M |
|
|
SRT
1788
DELISTED
Startek Inc.
SRT
| $5.52M | ﹤0.01% |
691,929
+30,429
| +5% | +$222K |
|
1789
OSI Systems
OSIS
$3.76B
| $5.52M | ﹤0.01% |
54,771
-241,437
| -82% | -$23.9M |
|
|
DQ
1790
Daqo New Energy
DQ
$991M
| $5.49M | ﹤0.01% |
536,000
+225,500
| +73% | +$1.92M |
|
|
AGTC
1791
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $5.49M | ﹤0.01% |
1,214,340
+163,280
| +16% | +$516K |
|
1792
TransDigm Group
TDG
$69.5B
| $5.49M | ﹤0.01% |
9,800
-41,800
| -81% | -$22.9M |
|
|
CBL
1793
DELISTED
CBL& Associates Properties, Inc.
CBL
| $5.48M | ﹤0.01% |
5,218,116
+806,100
| +18% | +$1.05M |
|
|
KDNY
1794
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $5.47M | ﹤0.01% |
927,662
+380,022
| +69% | +$2.07M |
|
|
TESS
1795
DELISTED
Tessco Technologies Inc
TESS
| $5.47M | ﹤0.01% |
487,400
+7,600
| +2% | +$96.5K |
|
1796
Nordson
NDSN
$17.2B
| $5.46M | ﹤0.01% |
+33,514
| New | +$5.29M |
|
|
DOO
1797
Bombardier Recreational Products
DOO
$4.73B
| $5.46M | ﹤0.01% |
119,700
+57,300
| +92% | +$2.56M |
|
1798
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.24B
| $5.45M | ﹤0.01% |
66,947
+34,372
| +106% | +$2.76M |
|
|
FG
1799
DELISTED
FGL Holdings Ordinary Shares
FG
| $5.45M | ﹤0.01% |
511,500
-339,200
| -40% | -$3.08M |
|
|
CISN
1800
DELISTED
Cision Ltd. Ordinary Share
CISN
| $5.43M | ﹤0.01% |
+544,910
| New | +$5.21M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.